After constructing the risk model, we screened out the signature composed of five ATGs (BID, BAG1, PTK6, NRG3, MAP1LC3C) with the best prognosis prediction performance, indicating these five ATGs play an important role in glioma. Here, NRG3 is linked to central nervous system cancer.